Published in Neurobiol Aging on May 11, 2013
HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. Nat Rev Neurol (2016) 1.71
Role of HIV in amyloid metabolism. J Neuroimmune Pharmacol (2014) 0.90
Atg7 deficiency impairs host defense against Klebsiella pneumoniae by impacting bacterial clearance, survival and inflammatory responses in mice. Am J Physiol Lung Cell Mol Physiol (2014) 0.84
HIV-1-Tat excites cardiac parasympathetic neurons of nucleus ambiguus and triggers prolonged bradycardia in conscious rats. Am J Physiol Regul Integr Comp Physiol (2014) 0.82
A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV. J Neuroimmune Pharmacol (2013) 0.82
HIV-1 stimulates nuclear entry of amyloid beta via dynamin dependent EEA1 and TGF-β/Smad signaling. Exp Cell Res (2014) 0.82
Release of calcium from endolysosomes increases calcium influx through N-type calcium channels: Evidence for acidic store-operated calcium entry in neurons. Cell Calcium (2015) 0.76
HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression. J Neuroinflammation (2016) 0.76
Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation. J Neuroimmune Pharmacol (2016) 0.75
HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity. Nat Struct Mol Biol (2017) 0.75
Transcriptional profile of HIV-induced nuclear translocation of amyloid β in brain endothelial cells. Arch Med Res (2014) 0.75
DNA Repair Interacts with Autophagy To Regulate Inflammatory Responses to Pulmonary Hyperoxia. J Immunol (2017) 0.75
Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV. Curr HIV/AIDS Rep (2017) 0.75
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem (1997) 6.52
Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev (2010) 6.35
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (1995) 4.95
Autophagy gone awry in neurodegenerative diseases. Nat Neurosci (2010) 4.72
Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci (2008) 4.63
Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol (2002) 3.23
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol (2010) 2.91
Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol (2000) 2.78
Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem (1999) 2.57
Studies on the internalization mechanism of cationic cell-penetrating peptides. J Biol Chem (2003) 2.53
The V-type H+-ATPase in vesicular trafficking: targeting, regulation and function. Curr Opin Cell Biol (2008) 2.44
Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med (2000) 2.34
Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A (2000) 2.23
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis (2002) 2.19
Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS (2005) 2.07
Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem J (2006) 1.92
Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging (2004) 1.88
Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology (2000) 1.88
CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology (2009) 1.85
Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. J Alzheimers Dis (2006) 1.83
Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol (1996) 1.78
Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol (2000) 1.75
Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J Neurosci (2006) 1.75
Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol (1991) 1.75
A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J Biol Chem (2004) 1.72
HIV tat and neurotoxicity. Microbes Infect (2006) 1.69
Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting. Science (2008) 1.67
Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS (2008) 1.65
Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry (1998) 1.62
Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J Biol Chem (2003) 1.57
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol (2009) 1.55
BACE is degraded via the lysosomal pathway. J Biol Chem (2005) 1.53
HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS (2005) 1.47
Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am J Pathol (2004) 1.43
Intraneuronal compartments of the amyloid precursor protein. J Neurosci (1993) 1.41
HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol Biol Cell (2004) 1.38
A dual function of V0-ATPase a1 provides an endolysosomal degradation mechanism in Drosophila melanogaster photoreceptors. J Cell Biol (2010) 1.38
Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. J Neurochem (1999) 1.32
The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol (2008) 1.31
Permeability of the blood-brain barrier to HIV-1 Tat. Exp Neurol (2005) 1.28
Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface. J Biol Chem (2003) 1.22
The endosomal-lysosomal system of neurons: new roles. Trends Neurosci (1995) 1.22
Modeling the endosomal escape of cell-penetrating peptides: transmembrane pH gradient driven translocation across phospholipid bilayers. Biochemistry (2005) 1.12
In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS. J Acquir Immune Defic Syndr (1994) 1.09
Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Neurobiol Dis (2007) 1.09
Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem Biophys Res Commun (2004) 1.08
Expression of beta-amyloid precursor protein-CD3gamma chimeras to demonstrate the selective generation of amyloid beta(1-40) and amyloid beta(1-42) peptides within secretory and endocytic compartments. J Biol Chem (1999) 1.07
Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Neurobiol Aging (2006) 1.02
LRP1 modulates APP trafficking along early compartments of the secretory pathway. Neurobiol Dis (2008) 1.02
HIV regulation of amyloid beta production. J Neuroimmune Pharmacol (2009) 1.02
Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production. Mol Cell Biol (2008) 1.02
HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes. Neurobiol Dis (2011) 1.01
Potential role for white matter lysosome expansion in HIV-associated dementia. J Acquir Immune Defic Syndr (2005) 1.00
Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. J Neurovirol (2004) 1.00
Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture. J Neurovirol (2001) 0.98
HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells. J Immunol (2003) 0.97
Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients. AIDS (2001) 0.96
Autophagy: an overlooked mechanism of HIV-1 pathogenesis and neuroAIDS? Autophagy (2008) 0.95
HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice. Int J Clin Exp Pathol (2009) 0.94
Attenuated neurotoxicity of the transactivation-defective HIV-1 Tat protein in hippocampal cell cultures. Exp Neurol (2009) 0.94
Role of endolysosomes in HIV-1 Tat-induced neurotoxicity. ASN Neuro (2012) 0.92
High-performance capillary electrophoresis for determining HIV-1 Tat protein in neurons. PLoS One (2011) 0.90
Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domain. J Neurosci Res (1995) 0.89
[HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system]. Rev Neurol (2011) 0.89
HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures. Neurosci Lett (2010) 0.87
Targeting the role of the endosome in the pathophysiology of Alzheimer's disease: a strategy for treatment. Sci Aging Knowledge Environ (2006) 0.87
Phosphorylation of LRP1 regulates the interaction with Fe65. FEBS Lett (2011) 0.82
Functional role of the low-density lipoprotein receptor-related protein in Alzheimer's disease. Neurodegener Dis (2006) 0.82
Endosomal abnormalities related to amyloid precursor protein in cholesterol treated cerebral cortex neuronal cells derived from trisomy 16 mice, an animal model of Down syndrome. Neurosci Lett (2007) 0.78
Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol (2006) 2.74
Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology (2012) 1.91
Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz. J Pharmacol Exp Ther (2012) 1.79
A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors. J Clin Invest (2011) 1.79
A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology (2013) 1.62
Brain glycogen decreases with increased periods of wakefulness: implications for homeostatic drive to sleep. J Neurosci (2002) 1.58
Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4. J Pharmacol Exp Ther (2002) 1.51
Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. J Neurochem (2009) 1.45
Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol Aging (2008) 1.35
GABA(B) receptor activation inhibits neuronal excitability and spatial learning in the entorhinal cortex by activating TREK-2 K+ channels. Neuron (2009) 1.27
A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain (2008) 1.25
ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain. Neurobiol Aging (2007) 1.24
Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation (2008) 1.22
Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers Dement (2010) 1.20
Presence and functional significance of presynaptic ryanodine receptors. Prog Neurobiol (2003) 1.12
Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. J Alzheimers Dis (2011) 1.10
Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Neurobiol Dis (2007) 1.09
Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? Trends Neurosci (2008) 1.07
Cholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability. J Neurosci (2010) 1.06
Doping-control urinalysis of a ginseng extract, Cold-FX, in athletes. Int J Sport Nutr Exerc Metab (2004) 1.06
Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem (2008) 1.04
Ethanol alters glutamate but not adenosine uptake in rat astrocytes: evidence for protein kinase C involvement. Neurochem Res (2002) 1.02
Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis (2010) 1.01
Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med (2010) 0.99
Activation of adenosine receptors inhibits tumor necrosis factor-alpha release by decreasing TNF-alpha mRNA stability and p38 activity. Eur J Pharmacol (2004) 0.97
Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice. J Neurosci Res (2010) 0.93
Role of endolysosomes in HIV-1 Tat-induced neurotoxicity. ASN Neuro (2012) 0.92
Disturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virus. J Neurovirol (2010) 0.92
A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease. Physiol Behav (2011) 0.92
A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120. J Neuroimmune Pharmacol (2011) 0.91
The human immunodeficiency virus coat protein gp120 promotes forward trafficking and surface clustering of NMDA receptors in membrane microdomains. J Neurosci (2011) 0.91
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study. PLoS One (2013) 0.90
Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity. Brain Res (2007) 0.90
The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load. J Neurochem (2006) 0.89
Assessment of post-mortem-induced changes to the mouse brain proteome. J Neurochem (2007) 0.89
Enzymes of adenosine metabolism in the brain: diurnal rhythm and the effect of sleep deprivation. J Neurochem (2003) 0.89
Homeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy. Expert Opin Drug Discov (2011) 0.88
Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet. J Alzheimers Dis (2010) 0.88
Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels. J Neurophysiol (2008) 0.88
Use of a glycolipid inhibitor to ameliorate renal cancer in a mouse model. PLoS One (2013) 0.88
Dual effects of ATP on rat hippocampal synaptic plasticity. Neuroreport (2004) 0.87
A sensitive HPLC-based method to quantify adenine nucleotides in primary astrocyte cell cultures. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.86
Endolysosome involvement in LDL cholesterol-induced Alzheimer's disease-like pathology in primary cultured neurons. Life Sci (2012) 0.86
Deficiency of a Niemann-Pick, type C1-related protein in toxoplasma is associated with multiple lipidoses and increased pathogenicity. PLoS Pathog (2011) 0.85
Involvement of oxidative stress in the rapid Akt1 regulating a JNK scaffold during ischemia in rat hippocampus. Neurosci Lett (2005) 0.85
Adenosine triphosphate released from HIV-infected macrophages regulates glutamatergic tone and dendritic spine density on neurons. J Neuroimmune Pharmacol (2013) 0.84
Spinal cord injury causes chronic liver pathology in rats. J Neurotrauma (2014) 0.83
Relationships between edema degree and clinical and biochemical parameters in posterior reversible encephalopathy syndrome: a preliminary study. Acta Neurol Belg (2012) 0.83
Informed decision-making on sympathomimetic use in sport and health. Clin J Sport Med (2002) 0.83
Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients. AIDS (2015) 0.83
Elevated plasma ceramides in depression. J Neuropsychiatry Clin Neurosci (2011) 0.82
Effects of moxibustion or acupoint therapy for the treatment of primary dysmenorrhea: a meta-analysis. Altern Ther Health Med (2014) 0.82
Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis. Am J Physiol Regul Integr Comp Physiol (2008) 0.81
Selected statins produce rapid spinal motor neuron loss in vitro. BMC Musculoskelet Disord (2012) 0.81
Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease? Clin Lipidol (2012) 0.81
Ketone bodies protection against HIV-1 Tat-induced neurotoxicity. J Neurochem (2012) 0.80
Microwave irradiation decreases ATP, increases free [Mg²⁺], and alters in vivo intracellular reactions in rat brain. J Neurochem (2012) 0.80
Ceramide metabolism analysis in a model of binge drinking reveals both neuroprotective and toxic effects of ethanol. J Neurochem (2014) 0.80
Purines and the Anti-Epileptic Actions of Ketogenic Diets. Open Neurosci J (2010) 0.80
Neuroprotective and antiretroviral effects of the immunophilin ligand GPI 1046. J Neuroimmune Pharmacol (2007) 0.79
GPI-1046 protects dorsal root ganglia from gp120-induced axonal injury by modulating store-operated calcium entry. J Peripher Nerv Syst (2009) 0.79
Targeted glycomics by selected reaction monitoring for highly sensitive glycan compositional analysis. Proteomics (2012) 0.79
The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids. Front Pharmacol (2012) 0.78
Neuroprotective actions of pyridoxine. Biochim Biophys Acta (2003) 0.78
Factors affecting longitudinal trajectories of plasma sphingomyelins: the Baltimore Longitudinal Study of Aging. Aging Cell (2014) 0.78
The ketogenic diet and epilepsy: is adenosine the missing link? Epilepsia (2009) 0.78
Purine level regulation during energy depletion associated with graded excitatory stimulation in brain. Neurol Res (2005) 0.77
Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury. Curr HIV Res (2014) 0.77
Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation. J Alzheimers Dis (2015) 0.76
Cellular Interactions and Signaling in neuroAIDS: Emerging Issues Colloquium. J Neuroimmune Pharmacol (2014) 0.76
Interaction of paroxetine with mitochondrial proteins mediates neuroprotection. Neurotherapeutics (2015) 0.76
Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD. J Parkinsons Dis Alzheimers Dis (2015) 0.76
Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A₂A receptor levels in rats subjected to neuroinflammation. J Neuroinflammation (2014) 0.75
Impaired long-term depression in P2X3 deficient mice is not associated with a spatial learning deficit. J Neurochem (2006) 0.75
Ryanodine receptor modulation by diadenosine polyphosphates in synaptosomal and microsomal preparations of rat brain. Eur J Pharmacol (2003) 0.75
Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot study. BMC Geriatr (2013) 0.75
The Psychiatric Impact of HIV. ACS Chem Neurosci (2017) 0.75
Informatic interrogation of CSF proteomic profiles from HIV-infected subjects implicates acute phase and complement systems in shifting cognitive status. AIDS (2017) 0.75
Inflammatory, oxidative and lipid perspectives on dementia in HIV-infected patients. Biomark Med (2007) 0.75
Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients. AIDS (2017) 0.75